CD276 expression
|
Head and Neck Cancer
|
CD276 expression
|
Head and Neck Cancer
|
MGC018 Sensitive: D – Preclinical
|
MGC018 Sensitive: D – Preclinical
|
CD276 expression
|
Breast Cancer
|
CD276 expression
|
Breast Cancer
|
MGC018 Sensitive: D – Preclinical
|
MGC018 Sensitive: D – Preclinical
|
CD276 expression
|
AML
|
CD276 expression
|
AML
|
s Sensitive: D – Preclinical
|
s Sensitive: D – Preclinical
|
CD276 expression
|
Neuroblastoma
|
CD276 expression
|
Neuroblastoma
|
B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical
|
B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical
|
CD276 expression
|
Pancreatic Ductal Adenocarcinoma
|
CD276 expression
|
Pancreatic Ductal Adenocarcinoma
|
B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical
|
B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical
|
CD276 expression
|
Prostate Cancer
|
CD276 expression
|
Prostate Cancer
|
MGC018 Sensitive: D – Preclinical
|
MGC018 Sensitive: D – Preclinical
|